[ad_1]
Studies focusing on the immune system in the cancer are becoming more prevalent in medicine. It is known that histiocytes are already effective in the fight against bacterial and epidemic infections. Because histiocytes recognize and attack foreign invaders. However, histiocytes are not very effective at fighting cancer because tumors arise from our own cells and have intelligent mechanisms to protect against immune attacks. Dr. Harvard University at the School of Medicine. The drug that was created in the study by Ashish Kulkarni is being treated in two directions. First, it prevents cancer cells from hiding and sending the "eat me" signal to histiocytes. The second prevents tumors from telling the histiocytes to be docile.
Source link